Molecular Basis of Inhibitory Activities of Berberine against Pathogenic Enzymes in Alzheimer's Disease
The natural isoquinoline alkaloid berberine possesses potential to treat Alzheimer's disease (AD) by targeting multiple pathogenic factors. In the present study, docking simulations were performed to gain deeper insights into the molecular basis of berberine's inhibitory effects against th...
Saved in:
Main Authors: | Hong-Fang Ji, Liang Shen |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | The Scientific World Journal |
Online Access: | http://dx.doi.org/10.1100/2012/823201 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Network pharmacology study on the mechanism of berberine in Alzheimer’s disease model
by: Yaoyi Zhang, et al.
Published: (2025-02-01) -
Inhibitory Activities of Thai Culinary Vegetables against Key Enzymes Relevant to Diabetes Mellitus and the Kinetics of Enzyme Inhibitions
by: Khakhanang Ratananikom, et al.
Published: (2024-01-01) -
Angiotensin I converting enzyme (ACE) inhibitory activity and antihypertensive effects of rice peptides
by: Jingjing Dong, et al.
Published: (2022-11-01) -
Advance in identified targets of berberine
by: Penghai Sun, et al.
Published: (2025-01-01) -
Study on Fermentation Preparation, Stability, and Angiotensin-Converting Enzyme Inhibitory Activity of Tomato Pomace Peptide
by: Ying Mu, et al.
Published: (2025-01-01)